The global medical industry experienced a 36% decline in the number of nanomedicine-related patent applications in Q3 2024 compared with the previous quarter. The total number of nanomedicine-related grants rose by 2% in Q3 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q3 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of nanomedicine-related patent applications in the medical industry was 142 in Q3 2024, versus 221 in the prior quarter.
The top five companies accounted for 8% of patenting activity
Analysis of patenting activity by companies shows that Stanford University filed the most nanomedicine patents within the medical industry in Q3 2024. The company filed 3 nanomedicine-related patents in the quarter. It was followed by Centre National de la Recherche Scientifique with 2 nanomedicine patent filings, Boston Scientific (2 filings), and Moderna (2 filings) in Q3 2024.
Patenting activity was driven by the US with a 65% share of total patent filings
The largest share of nanomedicine related patent filings in the medical industry in Q3 2024 was in the US with 65%, followed by China (7%) and Japan (5%). The share represented by the US was 13% higher than the 53% share it accounted for in Q2 2024.
For further understanding of GlobalData's Medical Devices: Patents Trends Q3 2024, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.